The selective Aurora B kinase inhibitor AZD1152 inhibits in vitro growth in small cell lung cancer (SCLC) cell lines

被引：0
|
作者：
Helfrich, B. [1 ]
Garcia, M. [1 ]
Haney, J. [1 ]
Bunn, P. A., Jr. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Dept Med, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72222-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors
    Gary K. Schwartz
    Richard D. Carvajal
    Rachel Midgley
    Scott J. Rodig
    Paul K. Stockman
    Ozlem Ataman
    David Wilson
    Shampa Das
    Geoffrey I. Shapiro
    Investigational New Drugs, 2013, 31 : 370 - 380
  • [22] Aurora B kinase inhibitor AZD1152 effectiveness alone or in combination with conventional chemotherapeutics in colon, pancreas, and breast cancer in vitro models
    Porcelli, L.
    Azzariti, A.
    Simone, G. M.
    Paradiso, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3418S - 3418S
  • [23] Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
    A Azzariti
    G Bocci
    L Porcelli
    A Fioravanti
    P Sini
    G M Simone
    A E Quatrale
    P Chiarappa
    A Mangia
    S Sebastian
    D Del Bufalo
    M Del Tacca
    A Paradiso
    British Journal of Cancer, 2011, 104 : 769 - 780
  • [24] Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
    Azzariti, A.
    Bocci, G.
    Porcelli, L.
    Fioravanti, A.
    Sini, P.
    Simone, G. M.
    Quatrale, A. E.
    Chiarappa, P.
    Mangia, A.
    Sebastian, S.
    Del Bufalo, D.
    Del Tacca, M.
    Paradiso, A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 769 - 780
  • [25] Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials
    Zhao, Yue
    Zheng, Zuguo
    Jin, Xuexiao
    Liang, Shaoshan
    Zhang, Changming
    Zhang, Mingchao
    Lang, Yue
    Li, Ping
    Liu, Zhihong
    EBIOMEDICINE, 2025, 112
  • [26] Enhancement of radiation response in p53 deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
    Tao, Yungan
    Zhang, Ping
    Frascogna, Valerie
    Castedo, Maria
    Bourhis, Jean
    Kroemer, Guido
    Deutsch, Eric
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3418S - 3419S
  • [27] Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
    Y Tao
    P Zhang
    F Girdler
    V Frascogna
    M Castedo
    J Bourhis
    G Kroemer
    E Deutsch
    Oncogene, 2008, 27 : 3244 - 3255
  • [28] Detection of surrogate markers of apoptosis in the peripheral blood of a preclinical tumour model treated with a selective inhibitor of Aurora B kinase (AZD1152)
    Wilkinson, R. W.
    Odedra, R.
    Heaton, S. P.
    Crafter, C.
    Growcott, J.
    Mundt, K.
    Cummings, J.
    Ward, T. H.
    Hegarty, C.
    Dive, C.
    EJC SUPPLEMENTS, 2006, 4 (12): : 144 - 144
  • [29] Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
    Tao, Y.
    Zhang, P.
    Girdler, F.
    Frascogna, V.
    Castedo, M.
    Bourhis, J.
    Kroemer, G.
    Deutsch, E.
    ONCOGENE, 2008, 27 (23) : 3244 - 3255
  • [30] The Topoisomerase I Poison CPT-11 Enhances the Effect of the Aurora B Kinase Inhibitor AZD1152 both In vitro and In vivo
    Nair, Jayasree S.
    de Stanchina, Elisa
    Schwartz, Gary K.
    CLINICAL CANCER RESEARCH, 2009, 15 (06) : 2022 - 2030
12345